EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Circulating TGF‐β1 Increases During Vaginal Progesterone Therapy in Women With a Short Cervix

Zdeněk Laštůvka iD, Viktor Černý iD, Anna Škvorová, Petra Petrásková, Olga Novotná, Helena Kopřivová, Jiří Hrdý iD, Michal Koucký iD

Scandinavian Journal of Immunology · 2026-11 · 104 (5)

DOI: 10.1111/sji.70165 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scandinavian Journal of Immunology, online erschienen am 05.11.2026. Verfasst von Zdeněk Laštůvka und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Obstetrics and Neonatology, General University Hospital in Prague and First Faculty of Medicine, Charles University, Prague…. Hauptthemen laut MEDLINE: Transforming Growth Factor beta1, Progesterone, T-Lymphocytes, Regulatory, Premature Birth. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Univerzita Karlova v Praze, Všeobecná Fakultní Nemocnice v Praze.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Progesterone is an effective tool for the secondary prevention of spontaneous preterm birth. The aim of this prospective exploratory pilot study was to evaluate the effect of progesterone administration on the number of regulatory T cell (Treg) populations and on the concentrations of the immunoregulatory cytokines IL‐10 and TGF‐β1 during in vivo progesterone treatment in women at risk of preterm delivery. Pregnant women with a singleton pregnancy (22–30 weeks of gestation) who were at risk of spontaneous preterm delivery and required progesterone therapy were included ( n = 21). Peripheral blood was sampled before progesterone administration and twice thereafter during treatment. Seventeen women attended the second visit, while only seven attended the third visit. The control group consisted of prospectively recruited low‐risk women ( n = 8). Treg numbers were determined by flow cytometry, and plasma concentrations of TGF‐β1 and IL‐10 were measured by ELISA. In women at risk, plasma TGF‐β1 concentrations increased significantly between the first and second sampling ( p ≤ 0.01) and remained at a similar level at the third sampling. In contrast, TGF‐β1 levels in the control group remained low without statistically significant change. IL‐10 concentrations were generally low in both groups. This pilot study was associated with an increase in the immunoregulatory cytokine TGF‐β1 following progesterone administration. Although TGF‐β1 is produced by several cell types in addition to Tregs, our findings raise the possibility that progesterone reinforces an immunoregulatory pathway relevant to the maintenance of pregnancy in women at risk of preterm birth; however, the present study does not establish this mechanism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transforming Growth Factor beta1ProgesteroneT-Lymphocytes, RegulatoryPremature BirthCervix UteriHumansFemalePregnancyAdultInterleukin-10Pilot ProjectsProspective StudiesAdministration, Intravaginal

Stichwörter der Autor:innen

TGF‐β1preterm labourprogesterone

Substanzen

Transforming Growth Factor beta1ProgesteroneInterleukin-10

Autor:innen und Institutionen

  • Department of Gynecology, Obstetrics and Neonatology, General University Hospital in Prague and First Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Institute of Clinical Immunology and Allergology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
  • Department of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University General University Hospital in Prague, Prague, Czech Republic.

ORCID-Profile: Zdeněk Laštůvka, Viktor Černý, Jiří Hrdý, Michal Koucký

Förderung

  • Univerzita Karlova v Praze
  • Všeobecná Fakultní Nemocnice v Praze

Zitieren

APA

Laštůvka, Z., Černý, V., Škvorová, A., Petrásková, P., Novotná, O., Kopřivová, H., Hrdý, J., & Koucký, M. (2026). Circulating TGF‐β1 Increases During Vaginal Progesterone Therapy in Women With a Short Cervix. Scandinavian Journal of Immunology, 104(5). https://doi.org/10.1111/sji.70165

Vancouver

Laštůvka Z, Černý V, Škvorová A, Petrásková P, Novotná O, Kopřivová H, et al. Circulating TGF‐β1 Increases During Vaginal Progesterone Therapy in Women With a Short Cervix. Scandinavian Journal of Immunology. 2026;104(5). doi:10.1111/sji.70165

BibTeX
@article{Latvka2026,
  author = {Laštůvka, Zdeněk and Černý, Viktor and Škvorová, Anna and Petrásková, Petra and Novotná, Olga and Kopřivová, Helena and Hrdý, Jiří and Koucký, Michal},
  title = {Circulating TGF‐β1 Increases During Vaginal Progesterone Therapy in Women With a Short Cervix},
  journal = {Scandinavian Journal of Immunology},
  year = {2026},
  volume = {104},
  number = {5},
  doi = {10.1111/sji.70165}
}
Kostenlos starten →